Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures.
暂无分享,去创建一个
Gordon Ramage | David F. Lappin | R. Rajendran | Craig Williams | G. Ramage | D. Lappin | William G. Mackay | Karen Smith | Craig Williams | Ranjith Rajendran | Karen Smith | Stephen Kerr | W. Mackay | S. Kerr
[1] R. Kolter,et al. A Pseudomonas aeruginosa quorum‐sensing molecule influences Candida albicans morphology , 2004, Molecular microbiology.
[2] Li Li,et al. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial , 2006, Genome Biology.
[3] S. Hirakawa,et al. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells , 2014, Respiratory Research.
[4] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[5] Freya Harrison,et al. Microbial ecology of the cystic fibrosis lung. , 2007, Microbiology.
[6] A. Hayward,et al. Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis , 1990, Journal of clinical microbiology.
[7] U. Ozbek,et al. Expression stability of six housekeeping genes: A proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR. , 2003, Journal of medical microbiology.
[8] B. Walker,et al. Novel Inhibitors of the Pseudomonas aeruginosa Virulence Factor LasB: a Potential Therapeutic Approach for the Attenuation of Virulence Mechanisms in Pseudomonal Infection , 2011, Antimicrobial Agents and Chemotherapy.
[9] J. Carlin,et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.
[10] Craig Williams,et al. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. , 2007, Journal of medical microbiology.
[11] Gerald B. Pier,et al. Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.
[12] J. Tournier,et al. In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase , 1985, Infection and immunity.
[13] E. Ben-Jacob,et al. Lethal protein produced in response to competition between sibling bacterial colonies , 2010, Proceedings of the National Academy of Sciences.
[14] B. Iglewski,et al. Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene , 1988, Journal of bacteriology.
[15] D. Ohman,et al. Pseudomonas aeruginosa Elastase Provides an Escape from Phagocytosis by Degrading the Pulmonary Surfactant Protein-A , 2011, PloS one.
[16] M. Surette,et al. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication , 2003, Molecular microbiology.
[17] M. Surette,et al. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients , 2008, Proceedings of the National Academy of Sciences.
[18] T. Theander,et al. Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases , 1988, Infection and immunity.
[19] S. Encarnación,et al. Interspecies competition triggers virulence and mutability in Candida albicans–Pseudomonas aeruginosa mixed biofilms , 2014, The ISME Journal.
[20] Gordon Ramage,et al. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. , 2010, FEMS microbiology letters.
[21] J. Bargon,et al. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis , 2003, Mycoses.
[22] A. Azghani. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. , 1996, American journal of respiratory cell and molecular biology.
[23] L. Hoffman,et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience , 2012, Thorax.
[24] A. Nicholson,et al. The pathology of cystic fibrosis , 2002 .
[25] S. Aaron,et al. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. , 2010, Chest.
[26] B. Iglewski,et al. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa , 1986, Journal of clinical microbiology.
[27] M. Bonten,et al. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[28] M. Singer. Pathogen-pathogen interaction , 2010, Virulence.
[29] S. Lynch,et al. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications , 2011, Expert review of respiratory medicine.
[30] Martin H. Schmidt,et al. Epidemiology and Pathogenesis , 2022 .
[31] S. Bell,et al. Exacerbations in cystic fibrosis: 2 · Prevention , 2007, Thorax.
[32] J. Alcorn,et al. Degradation of Pulmonary Surfactant Protein D by Pseudomonas aeruginosa Elastase Abrogates Innate Immune Function* , 2004, Journal of Biological Chemistry.
[33] S. Leroy,et al. The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management , 2012, PloS one.
[34] J. Emerson,et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.
[35] B. Peters,et al. Polymicrobial Interactions: Impact on Pathogenesis and Human Disease , 2012, Clinical Microbiology Reviews.
[36] B. Finlay,et al. Quorum sensing in bacterial virulence. , 2010, Microbiology.
[37] C. Goss,et al. Exacerbations in cystic fibrosis · 1: Epidemiology and pathogenesis , 2007, Thorax.
[38] M. Surette,et al. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. , 2011, Canadian journal of microbiology.
[39] G. Valenza,et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[40] J. Bargon,et al. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. , 1999, Respiratory medicine.
[41] P. A. Schad,et al. Cloning and characterization of elastase genes from Pseudomonas aeruginosa , 1987, Journal of bacteriology.
[42] Deborah A Hogan,et al. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation , 2013, Microbiome.
[43] J. Colmer,et al. Characterization of elastase-deficient clinical isolates of Pseudomonas aeruginosa , 1996, Infection and immunity.